Great teamwork at the Pediatric Cancer Immunotherapy Initiative @UFHealthCancer @UFMBI @Rosen_NeuroOnc shows that RNA-lipid particles mediate immune checkpoint inhibition and epitope spreading by early response type-I interferons. https://t.co/dIzQadDDyR
Deconstructing the lair in glioblastoma
Jianping Huang & team @uflorida find block of the immune checkpoint LAIR1 with an antibody or 3-in-1 CAR T cells enhances antitumor response: https://t.co/tzIC0aSf2h
Check out the effect of a LAIR1 blocking antibody on CAR T cells, M2-like macrophages, and human glioma tumor spheres.
UF Health Cancer Center researchers have found that a genetic alteration may predict the outlook for patients with Ewing sarcoma. Published in @MolOncology, the findings could ultimately help clinicians personalize clinical-decision-making.
Read more: https://t.co/G2hV8INQ8v
If you are looking for US clinical experience in #neurosurgery, this is a great opportunity! Apply for Neurosurgery Pre-Residency #Fellowship at University of Missouri #Match2025
Attention @UFMedicine faculty! The 2025-26 R01 Boot Camp mentee application opens April 1st, 2025! The R01 Boot Camp is a 9-month team-science and mentorship-focused program designed to help faculty member receive R01 or equivalent grants. Learn more at https://t.co/JUWX019FfZ.
.@UFHealth pediatric oncologist @JohnLigon has launched a new clinical trial to test a novel @UF-developed mRNA lipid nanoparticle (RNA-LP) in children with recurrent high-grade glioma and recurrent osteosarcoma: https://t.co/a7WaI6K8A1
Happy to share our article in Blood Advances. Great work by grad student Dr. Nam Nguyen, lab alumni Dr. Raffie and current postdoc Dr. Phani Parcha
Genome-wide CRISPR/Cas9 screen identifies AraC-daunorubicin-etoposide ... https://t.co/POEjOuZQx6
Dr. Christian Capitini has been appointed to serve as the acting director of @UWCarbone. He currently serves as the chief of @WiscPediatrics Division of Hematology, Oncology and Bone Marrow Transplant. He succeeds Dr. Howard Bailey who has served as director since 2015.
IL15 increases the expansion of CAR T cells and induces antitumor responses in patients with GPC3+ solid tumors (i.e. liver cancer).
https://t.co/ybNobLrQvy